Recent Finacing
Recent Raise
Nemesis Bioscience develops bacterial cybergenetics using multiplexed RNA-guided endonucleases to inactivate beta-lactamase-mediated resistance, offering Symbiotics and Transmids for clinical, veterinary, and industrial antimicrobial delivery.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors